Treatment of rosacea with isotretinoin.
A multicenter trial of isotretinoin in severe papulopustular rosacea in adult patients was undertaken to evaluate the efficacy and safety of this treatment. A 20-week course of therapy was instituted in 92 patients from 11 dermatology departments. At the end of the study period, isotretinoin was found to be highly effective in the clearing of refractory rosacea lesions.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D001762:Blepharitis / Q000150:complications / Q000188:drug therapy; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D003231:Conjunctivitis / Q000150:complications / Q000188:drug therapy; D005260:Female; D006801:Humans; D015474:Isotretinoin; D008297:Male; D008875:Middle Aged; D012393:Rosacea / Q000188:drug therapy*; D014212:Tretinoin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014280:Triglycerides / Q000097:blood; D014606:Uveitis, Anterior / Q000150:complications / Q000188:drug therapy
D014280:Triglycerides; D014212:Tretinoin; D002784:Cholesterol; D015474:Isotretinoin